Ann: March 2025 Quarterly Activity Report and Appendix 4C, page-7

  1. 4,548 Posts.
    lightbulb Created with Sketch. 4699
    Any anticancer efficacy observed after the single agent lead in dose in p1a validates RC220 as a P2/3 asset.
    Last edited by johndprent: 23/04/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.15
Change
-0.040(3.38%)
Mkt cap ! $198.9M
Open High Low Value Volume
$1.22 $1.22 $1.13 $132.0K 114.0K

Buyers (Bids)

No. Vol. Price($)
1 2390 $1.14
 

Sellers (Offers)

Price($) Vol. No.
$1.18 4805 1
View Market Depth
Last trade - 15.57pm 04/07/2025 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.